Immunic is trading at $9.86, up 6.02% in after-hours trading; the reason for the move remains unclear.
- The supplied market data is mixed and does not clearly explain the rise.
- Immunic’s latest listed release was dated September 29 and concerned inducement grants; its news page lists no September 30 announcement.